Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06355895 · ClinicalTrials.gov registry record · NA
Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
A NA study of Upper Abdominal Malignancies, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06355895 is a NA study of Upper Abdominal Malignancies that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06355895, a NA study of Upper Abdominal Malignancies, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into estimates of dose-volume distribution within normal liver tissue, as well as affecting day-to-day setup fidelity and organ alignment for treatment. This prospective study will examine how diurnal and fast-fed variations in liver volume affect treatment planning for abdominal SBRT.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Standardized high-carbohydrate meal
Study Locations (1)
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06355895
The ClinicalTrials.gov registry entry for NCT06355895 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Abdominal Malignancies appearing as the primary indexed condition, and to 1 intervention - of which Standardized high-carbohydrate meal is the first listed.
NCT06355895 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06355895 about?
NCT06355895 is a clinical study titled "Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies". Standard planning constraints for liver SBRT incorporate strict dose-volume limits for normal liver parenchyma to minimize the risk of radiation-induced liver disease. The presence of diurnal and fasting/fed variations in liver volume therefore carry substantial potential for introducing errors into...
What is the current status of trial NCT06355895?
This trial is currently recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2024-05-16. Estimated completion is 2026-03-31.
What conditions does trial NCT06355895 study?
This clinical trial studies the following conditions: Upper Abdominal Malignancies.
What interventions are being tested in trial NCT06355895?
The interventions under investigation include: Standardized high-carbohydrate meal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06355895?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06355895 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.